Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2006
05/17/2006EP1274711B1 New aza-indolyl derivatives
05/17/2006CN1774632A The detection and identification of saxiphilins using saxitoxin-biotin conjugates
05/17/2006CN1774490A 有机电致发光装置和铂化合物 Organic electroluminescent devices and platinum compounds
05/17/2006CN1774439A Heterobicyclic compounds used as fungicides.
05/16/2006US7045638 Coloristic and rheological properties and use for pigmenting high for pigmenting high molecular mass materials
05/16/2006US7045637 Pigment dispersants based on diketopyrrolopyrrole compounds and pigment preparations
05/16/2006US7045118 Delivery of compounds for the treatment of migraine through an inhalation route
05/16/2006US7045117 Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives
05/16/2006US7044095 Roller tappet with cold advance
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/11/2006WO2006050435A1 Heterocyclical chromophore architectures
05/11/2006WO2006050128A2 Heterocyclical chromophore architectures
05/11/2006WO2006049339A1 Novel fused imidazole derivative
05/11/2006WO2006049013A1 Compound containing fused ring and organic electroluminescent element employing the same
05/11/2006WO2006019660A3 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
05/11/2006WO2006018280A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
05/11/2006WO2006018279A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
05/11/2006WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
05/11/2006WO2005040170A8 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
05/11/2006US20060100432 Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
05/11/2006US20060100431 Biologically active compounds
05/11/2006US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/11/2006US20060100200 Selective oxidation of the the N-atom of the quinoline group using a peroxomonosulfuric acid, peroxodisulfuric acid or their salts in the presence of a ketone; N-atoms of the 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one scaffold are not oxidized
05/11/2006US20060100199 Novel condensed imidazole derivatives
05/11/2006US20060100198 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one
05/11/2006DE102004053192A1 2-Alkoxy-6-alkyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-alkoxy-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
05/11/2006CA2589102A1 Pyridazine compounds and methods for using the compounds to treat inflammatory diseases
05/11/2006CA2586259A1 Novel fused imidazole derivative
05/11/2006CA2584869A1 Heterocyclical chromophore architectures
05/11/2006CA2584792A1 Heterocyclical chromophore architectures
05/10/2006EP1656002A2 Organic light emitting device
05/10/2006EP1655303A2 Hydroxylamine esters as polimerization initiators
05/10/2006EP1655301A1 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
05/10/2006EP1654263A1 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
05/10/2006EP1654250A1 Substituted pyridones and pyrimidinones with antiinflammatory properties
05/10/2006EP1654239A2 Peptide deformylase inhibitors
05/10/2006EP1653969A2 Pyrrolo 1,2-b pyridazine derivatives
05/10/2006EP1427731B1 Process for the preparation of highly pure triethylene diamine
05/10/2006EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters
05/10/2006EP1196626B1 Methods for identifying inhibitors of signaling molecules
05/10/2006CN1771298A Fluorescent diketopyrrolopyrroles
05/10/2006CN1771257A Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
05/10/2006CN1771234A Process for preparing pyrrolotriazine kinase inhibitors
05/10/2006CN1771231A Calcium receptor modulating compound and use thereof
05/10/2006CN1771050A Macrocyclic hepatitis c serine protease inhibitors
05/10/2006CN1771040A Remedy for diabetes.
05/10/2006CN1769286A Compound and pharmaceutical composition for treating nasal oversecreation and chronic obstructive pulmonary disease
05/10/2006CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/10/2006CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/10/2006CN1768745A Agents for improving excretory potency of urinary bladder
05/10/2006CN1255408C Method for synthesizing 3 (or8)-(1-methoxyethyl)-8-(or3)-(1-hydroxyethyl)-deuteroporphyrin IX
05/10/2006CN1255407C Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines
05/10/2006CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods
05/10/2006CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase
05/09/2006USRE39094 absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic cancer therapy
05/09/2006US7042755 High density non-volatile memory device
05/09/2006US7041836 Antibiotic compounds
05/09/2006US7041833 3-step synthesis of pyrazolotriazole couplers and coupler intermediates
05/09/2006US7041819 Separation technology, environmental remediation, and biomedical applications such as dialysis and drug delivery
05/09/2006US7041696 Induce inflammation, immunology response; autoimmune disease; antiarthritic agents
05/09/2006US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
05/09/2006US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/09/2006US7041671 N-(1-ethylpropyl)- or N-(1-methylpropyl)-7-(6-methoxy-2-methylpyridin-3-yl)-2,6-dimethylpyrrolo[1,2-b]pyridazin-4-amine or their salts, used for treating disorders manifesting hypersecretion of CRF receptors, such as anxiety, and depression.
05/09/2006US7041666 Adenosine A2a receptor antagonists
05/09/2006US7041235 Fluorescent diketopyrrolopyrrole analogues
05/04/2006WO2006047452A2 Reactive 1,3’-crosslinked carbocyanines and their bioconjugates
05/04/2006WO2006047354A1 Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-jun n terminal kinases (jnk) and p-38 kinases
05/04/2006WO2006047317A1 Pyrrolotriazine compounds
05/04/2006WO2006047017A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
05/04/2006WO2006046497A1 Optical filter and its applications, and porphyrin compound used in optical filter
05/04/2006WO2006046024A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors
05/04/2006WO2006046023A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors
05/04/2006WO2006045828A1 Hiv inhibiting bicyclic pyrimidine derivatives
05/04/2006WO2006045716A1 Novel diazabicyclic aryl derivatives and their medical use
05/04/2006WO2006045430A1 Imidazo-benzodiazepine derivatives
05/04/2006WO2006045429A1 Halogen substituted benzodiazepine derivatives
05/04/2006WO2006032994A3 Muscarinic receptor antagonists
05/04/2006WO2006027628A3 Naphthalimide derivatives as antiviral agents
05/04/2006WO2006007378A3 Pyrrolotriazine kinase inhibitors
05/04/2006WO2006005726A3 Heterocyclic compounds
05/04/2006WO2005112938A3 Disalt inhibitors of il-12 production
05/04/2006WO2005025681A3 A system for and a method of manufacturing personal golf putters
05/04/2006US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same
05/04/2006US20060094736 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006US20060094707 Constrained compounds as CGRP-receptor antagonists
05/04/2006US20060094706 e.g. 7-Biphenyl-4-yl-5-(4-chlorophenyl)pyrazole[1,5a]pyrimidine-2-carbocylic acid ethyl ester; serine/threonine and tyrosine protein kinases inhibitor; vascular endothelial and fibroblast growth factor receptor antagonist; antiproliferative, antitumor, antiinflammatory agent, viricide
05/04/2006CA2730374A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
05/04/2006CA2585113A1 Tetracyclic indole derivatives as antiviral agents
05/04/2006CA2584838A1 Novel diazabicyclic aryl derivatives and their medical use
05/04/2006CA2584259A1 Imidazo-benzodiazepine derivatives
05/04/2006CA2581223A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
05/04/2006CA2580475A1 Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-jun n terminal kinases (jnk) and p-38 kinases
05/04/2006CA2577588A1 Hiv inhibiting bicyclic pyrimidine derivatives
05/03/2006EP1651685A1 Cucurbituril-containing polymer, stationary phase and column using the same
05/03/2006EP1651653A1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
05/03/2006EP1651651A1 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof
05/03/2006EP1651650A1 The use of fused ring-1,2,4-benzotriazine derivatives as herbicides or plant growth regulators for the control of undesired plants or vegetation, compounds and compositions thereof, and processes for their preparation
05/03/2006EP1651649A1 Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
05/03/2006EP1651648A2 Compounds and compositions as protein kinase inhibitors